The treatment of relapsed refractory chronic lymphocytic leukemia.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2011, Issue , 2011, Pages 110-118

  Brown, Jennifer R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FLUDARABINE; VIDARABINE;

CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFECT; DRUG RESISTANCE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; RECURRENT DISEASE; REVIEW;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOTHERAPY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; RECURRENCE; VIDARABINE;

EID: 84859410688     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2011.1.110     Document Type: Review

References (0)